Gevokizumab Completed Phase 2 Trials for Osteoarthritis (OA) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01683396Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand
NCT01882491Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand